Adaptimmune Therapeutics Plc (ADAPY)
0.03
0.00 (0.00%)
USD |
OTCM |
Jun 08, 16:00
Adaptimmune Therapeutics SG&A Expense (Quarterly) : 18.71M for June 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Kiniksa Pharmaceuticals International Plc | 61.15M |
| Autolus Therapeutics Plc | 39.89M |
| Aptorum Group Ltd. | 0.2117M |
| Bicycle Therapeutics Plc | 17.44M |
| Barinthus Biotherapeutics Plc | 2.524M |